ELECTRODE ARRANGEMENT IN A CARDIAC ABLATION CATHETER AND METHODS FOR USE
20220354567 · 2022-11-10
Inventors
- Yonathan F. Melman (Salt Lake City, UT, US)
- Paul MELMAN (Newton, MA, US)
- Meir M. BROSH (Newton Center, MA, US)
Cpc classification
E03F1/002
FIXED CONSTRUCTIONS
G06F3/04842
PHYSICS
A61B18/1492
HUMAN NECESSITIES
G06F2203/04806
PHYSICS
G06F3/0481
PHYSICS
E03F5/0404
FIXED CONSTRUCTIONS
International classification
Abstract
A novel cardiac ablation catheter is based on the principle that the field gradient near the electrode surface is reduced by a truncated dome shape which reduces the ratio of the current magnitude near the electrode-tissue interface to that in the tissue. Thus, for a given power, a deeper lesion can be created at a lower applied power reducing the risk of steam pop and overheating of the surrounding blood pool. The result is a reduction in spurious current which does not contribute to tissue ablation but undesirably increases heating of the blood pool near the ablation site. Methods of use are also described.
Claims
1. An ablation catheter for ablating cardiac tissue comprising: a catheter body having a longitudinal axis, the catheter body including a distal tip; an ablation electrode proximate to the distal tip of the catheter body; wherein the electrode has at least a partial dome shape which is at least partially electrically conductive.
2. The ablation catheter of claim 1 wherein the electrode further comprises a ceiling region which is non-conductive.
3. The ablation catheter of claim 1 wherein the dome shape of the electrode has a central axis which is parallel to the longitudinal axis of the catheter body.
4. The ablation catheter of claim 1 wherein the dome shape of the electrode has a central axis which is perpendicular to the longitudinal axis of the catheter body.
5. The ablation catheter of claim 1 comprising a plurality of electrodes spaced about the catheter body.
6. The ablation catheter of claim 5 wherein each of the plurality of electrodes has a central axis.
7. The ablation catheter of claim 6 wherein one or more of the central axes are parallel to one another or be at an angle to each other.
8. The ablation catheter of claim 6 wherein one or more of the central axes are non-parallel to one another.
9. The ablation catheter of claim 1 further comprising a temperature sensor in proximity to the electrode.
10. The ablation catheter of claim 1 further comprising at least one fluid aperture.
11. The ablation catheter of claim 10 having a fluid flow inlet aperture and a separate fluid flow outlet aperture.
12. The ablation catheter of claim 1 wherein the electrode is made of conductive mesh.
13. The ablation catheter of claim 1 wherein the electrode is made of conductive foldable mesh.
14. The catheter electrode of claim 1 wherein the dome shape of the electrode comprises a rim, and wherein the rim is covered by an insulating material.
15. An ablation catheter system for ablating cardiac tissue comprising: an ablation catheter having: a catheter body having a longitudinal axis, the catheter body including a distal tip; at least one ablation electrode proximate to the distal tip of the catheter body; wherein the electrode has at least a partial dome shape which is at least partially electrically conductive; and an RF or PFA power generator connectable to the ablation catheter.
16. The ablation catheter system of claim 15 wherein the power generator is configurable to deliver RF or PFA power with time-dependent amplitude.
17. A method for cardiac ablation comprising the steps of: a) providing an ablation catheter comprising: a catheter body having a longitudinal axis, the catheter body including a distal tip; at least one ablation electrode proximate to the distal tip of the catheter body; wherein the electrode has at least a partial dome shape which is at least partially electrically conductive; b) advancing the catheter tip to a cardiac treatment site of a patient; c) delivering RF power to the electrode of the ablation catheter to ablate cardiac tissue.
18. The method of claim 17 wherein the cardiac tissue proximate to the tip of the catheter during the delivering step is heated less than compared to an electrode not having an at least a partial dome shape which is at least partially electrically conductive.
19. The method of claim 17 wherein the cardiac tissue proximate to the tip of the catheter during the delivering step exhibits fewer steam pops than compared to an electrode not having an at least a partial dome shape which is at least partially electrically conductive.
20. The method of claim 17 wherein the cardiac tissue ablated is located greater than 0.6 cm from the catheter tip and is ablated more quickly than compared to an electrode not having an at least a partial dome shape which is at least partially electrically conductive.
Description
BRIEF DESCRIPTION OF DRAWING(S)
[0022] The drawings are not necessarily to scale or exhaustive. Instead, emphasis is generally placed upon illustrating the principles of the inventions described herein. The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate several embodiments consistent with the disclosure and together with the description, serve to explain the principles of the disclosure. The patent or application file contains at least one drawing executed in color. Copies of this patent or patent application publication with color drawing(s) will be provide by the Office upon request and payment of the necessary fee. In the drawings:
[0023]
[0024]
[0025]
[0026]
[0027]
[0028]
[0029]
[0030]
[0031]
[0032]
DETAILED DESCRIPTION
[0033] Reference will now be made in detail to exemplary embodiments, discussed with regards to the accompanying drawings. In some instances, the same reference numbers will be used throughout the drawings and the following description to refer to the same or like parts. Unless otherwise defined, technical or scientific terms have the meaning commonly understood by one of ordinary skill in the art. The disclosed embodiments are described in sufficient detail to enable those skilled in the art to practice the disclosed embodiments. It is to be understood that other embodiments may be utilized and that changes may be made without departing from the scope of the disclosed embodiments. Thus, the materials, methods, and examples are illustrative only and are not intended to be necessarily limiting.
[0034] According to exemplary embodiments of the disclosure, various geometries of the indentation at the tip can reduce spurious currents which do not contribute to tissue ablation but increase heating of the blood pool. According to illustrative embodiments, a method is described to modulate the applied power to further increase of the ablation depth.
[0035] According to further aspects of the disclosure the use of a shaped catheter tip designed to reduce the electric field magnitude at the catheter-tissue interface is described. The electrical field generated by this tip falls off more slowly as the distance from the electrode surface into the tissue increases. This increases the magnitude of the field penetrating the tissue relative to its value at the electrode interface and thus extends the depth of safe ablation without causing high field values near the tip itself. The geometry of the shaped catheter tip is such that an indented surface of the catheter tip faces the surface of the cardiac tissue and can reduce the magnitude of the electric field at the catheter tissue interface.
[0036] Referring to
[0037] Referring to
[0038]
[0039] In some embodiments, the electrode can be made of a conductive mesh. In further embodiments, the conductive mesh can be foldable. In other embodiments the electrode can be formed of a conductive metallic material.
Examples
[0040] An FEF catheter was constructed with a hemispherical truncated dome forming an electrode tip as described herein. Ablation was performed ex vivo in porcine hearts and ablation characteristics were examined using both tissue sectioning and real-time thermal imaging.
[0041] As described below in detail, a THERMOCOOL SMARTTOUCH SF porous-tip catheter available from Biosense Webster was used for comparison. RF lesions were 9.1±1.0 mm wide by 6.1±1.1 mm deep with ablation using an irrigated-tip Thermocool SF catheter. In contrast, lesions created using FEF ablation were 16.1±2 mm wide and 15.2±1.1 mm deep. Steam pops were much less frequent with FEF technology (6.7% incidence for FEF vs. 15% with Thermocool). Thermal imaging demonstrated that in contrast to an irrigated tip RF catheter, the FEF catheter generated a uniform temperature profile down to a maximum depth exceeding 15 mm. As summarized in the table, a control catheter without the FEF tip but similarly insulated to the FEF tip did not ablate significantly deeper than the Thermocool catheter, confirming the role of the truncated dome in the FEF effect.
[0042] Biophysical Model of FEF Ablation and Methodology
[0043] Described herein is the electric field model used to demonstrate that FEF catheters constructed in accordance with disclosed embodiments achieve a more uniform field distribution. Electric field along the axis of symmetry of the catheter tip are computed for an FEF-generated field and that of a standard tip for comparison.
[0044] The field along the symmetry axis is calculated as follows. The electric field of a conductive structure can be calculated using Coulombs law which relates its value E (field amplitude) to a point charge Q at a distance r, where the field E is a vector pointing along r with magnitude:
[0045]
[0046] With reference to
[0048] The field E(z), because of symmetry of the hemisphere, has only one component at point B, which is along the z direction. Its value depends on the distance from the hemisphere and the size of the aperture, θmin.
[0049] A standard electrode has a cylindrical tip and the shape of the tip when ablating end-on is a flat disc. The field of a flat disc at distance z from its center on its symmetry axis is given by:
[0050] Squaring the two equations above for the hemispherical and commercial catheter tips yields an expression for the predicted power delivered to the tissue along the axis of the catheter during ablation. These data are graphed for comparison in
[0051] Catheter Construction
[0052] The FEF electrode for this study was constructed as a tip attached to a standard, commercially available electrode. The tip is machined from a copper cylinder, 5 mm in diameter and 8 mm in length. The tissue end of the rod is shaped so as to create a hollow depression. In the experimental catheter, the diameter of the hollow was approximately 3.8 mm. A 1 mm hole at the end of the catheter allows for communication of saline in the catheter tip with the circulating bath. The schematics of the FEF tip is shown in
[0053] The proximal end of the tip as used in these examples was attached to the end of a commercial tip in a way as to provide mechanically stable connection and ensure electrical contact between the two tips. The outsides of both tips were coated with an electrically insulating lacquer coating, and a plastic rim was applied around the FEF indented surface to complete the insulation. This prevents current from flowing directly into the surrounding blood pool and eliminates areas of sharp curvature where the electric field is highest. Hence, in the tip used in this experiment, the current flow was confined to the truncated surface.
[0054] As a further control, a catheter was constructed and insulated in an identical manner to the FEF catheter, but with a planar end instead of the toroidal truncated dome of the FEF surface. The same type of insulating material was used on the control insulated catheter tip and the FEF catheter, leaving only the tips exposed for ablation. A schematic of this tip is shown in
[0055] Experimental Tissue Preparation
[0056] Fresh intact porcine hearts were acquired within 2-4 hours of sacrifice. The LVs were harvested, and rectangular strips of myocardium were (2.5×5 cm×myocardial thickness [>2.0 cm]) excised. The LV myocardial samples were submerged in a circulating bath of NS (0.9% NaCl) continuously heated to 37° C. The ablation system for the FEF RF arm included: a RF3000 RF generator and a power-controlled FEF RF catheter. The ablation system for the irrigated RF catheter arm consisted of a Stockert RF generator, Smart Ablate irrigation pump (with flow rate set to 15/mi min during RF), and 3.5 mm THERMOCOOL SMARTTOUCH/Surround flow open irrigated-tip ablation catheter (Biosense Webster, Diamond Bar, Calif.). An indifferent electrode (grounding patch) in the fluid bath completed the electric circuit.
[0057] Radiofrequency Lesion Formation
[0058] RF lesions were created with the FEF ablation catheter's tip submerged in the fluid bath and positioned perpendicular to the endocardial surface of myocardial tissue samples during lesion applications. RF energy was delivered in a power-controlled mode. In initial experiments a significantly increased incidence of steam pops above 20 W was noted, while effective lesion formation was observable at this power output. Hence, for purposes of these examples, comparing ablation lesions to irrigated-tip Thermocool catheters, ablation applications were performed at 20 W. Slow and continuous lesion expansion over several minutes was observed. Ablation lesions were thus performed for either 2 minutes or 4 minutes per lesion. Tip temperature, starting impedance, and impedance drop were continuously monitored during each ablation lesion.
[0059] Irrigated Ablation Group
[0060] RF lesions in the irrigated catheter ablation group were performed with the ablation catheter tip submerged in the fluid bath and positioned perpendicular to the endocardial surface of tissue samples. Both NS (0.9% NaCl) or HNS (0.45% NaCl) were used for irrigation to allow comparison to RF ablation under a range of well-studied conditions. During RF applications, the catheter tip was irrigated with room temperature NS or HNS at a flow rate of 15 mL/min.
[0061] In both the NS and HNS groups, RF energy was delivered for 90 seconds per lesion at a constant power setting of 40 Watts (W), contact force of 10-15 grams (g). These settings were selected to produce optimal lesion size with little increase in lesion size with longer durations. Longer duration lesions were attempted for a more direct comparison to FEF ablation, however longer duration lesions at 40 W caused a high rate of steam pops so power was reduced to 30 W with NS irrigant for two and four minutes for a more direct comparison to FEF catheters. These parameters allowed a comparison of FEF catheters to irrigated tip RF catheters under optimal conditions. The FEF catheters are not irrigated and lesions were applied to similar tissue slices in the same circulating bath under similar conditions. Contact force, tip temperature, starting impedance, and impedance drop were continuously monitored during each ablation lesion.
[0062] Infrared Thermography and Optical Imaging
[0063] Digital infrared thermal imaging (ITI) videos were recorded during RF applications using a 3rd generation infrared thermal camera (Shot PRO, Seek Thermal, Santa Barbara, Calif.). The infrared camera's image resolution was 320×240 (76,800 pixels) at a frame rate of <9 Hz. The thermal resolution of the camera was <0.07° C. with spectral range of 7.5-14 microns and maximum detectable temperature range of −40° C. to 330° C. The infrared camera's temperature range was manually set to 0° C. to 120° C. during experiments. The camera's emissivity was set to 0.90 based on previous estimates of emissivity in biologic tissue.
[0064] For each lesion, ITI video recordings were reviewed and still images were acquired at 30 second intervals (time: 0 sec, 30 secs, 60 secs, 90 secs, 120 secs, 150 secs, 180 secs, 210 secs, and 240 secs). Using proprietary software (Seek Fusion™, Seek Thermal, Santa Barbara, Calif.) ITI images were electronically registered and merged with optical images taken concurrently by the infrared thermal camera. Areas circumscribed by 100° C. Isotherms (mm.sup.2) were measured using commercially available image analysis software (Digimizer, MedCalc Software Ltd. Belgium) from video stills taken at 30 second intervals starting from onset to end of RF delivery. A ruler placed nearby the lesion set during image acquisition was used for calibration of measurements. In event of steam pops, RF delivery was continued unless the catheter tip was dislodged from the myocardial tissue interface during lesion application.
[0065] The still image for each lesion at 90 seconds was used to compare the temperature variation between catheters as a function of depth. The temperature was measured at 2 mm increments and averaged data used to create a plot comparing the temperature variation during lesion formation.
[0066] Tissue Staining and Analysis
[0067] Immediately following RF delivery, the myocardial samples were sliced in cross-section through the center of each lesion. One of the sliced sides of the sample was submerged and stained for 4 hours in 2% triphenyl tetrazolium chloride (TTC) solution to aid in differentiating the border of non-viable myocardial tissue of the lesion from healthy myocardium which stains red due to preservation of dehydrogenase enzymes. Optical photographs were obtained following TTC staining. Measurements of lesion diameter and depth at maximum lesion diameter were made using a digital micrometer.
[0068] Statistical Analysis and Results
[0069] Continuous variables are expressed as mean±standard deviation if normally distributed or otherwise as median (interquartile range [IQR]; 25th-75.sup.th percentile). A Student t-test or Mann-Whitney U-test was used for parametric and nonparametric continuous variables, respectively. SPSS software was used to perform all calculations (Version 25, IBM, Chicago, Ill.). A p value of <0.05 was considered statistically significant.
[0070] Results show that FEF ablation technology creates a different electric field configuration than conventional RF catheters.
[0071] As described herein, ex vivo data demonstrates the superior ability of FEF ablation to target deeper tissues than conventional RF catheter technology. FEF lesions delivered at 20 W over 4 minutes were markedly deeper and wider than RF lesions (15.2±1.1 mm deep×16.1±2 mm wide). Importantly the incidence of steam pops was lower with FEF than with the Thermocool catheter using our setup. With RF ablation an incidence of 15% of steam pops was observed, comparable to other reports in ex vivo tissue. The incidence of steam pops was significantly lower with the FEF catheter, with pops occurring on 6.7% (2 out of 30) of lesions.
[0072] In these examples the control catheter was used under similar conditions as the FEF catheter. Using a power-controlled mode ablation above 20 W was found to invariably led to steam pops, so experiments were limited to 20 W. Due to the smaller area exposed to the tissue the starting impedance was higher for this catheter (175.7±28.0 vs 124.9±5.2 ohms for the FEF catheter). Impedance drop was similar for both (49.6±22.2 ohms for the insulated catheter vs 45.5±5.1 ohms for the FEF catheter). Lesions were 9.8±1.1 mm wide by 6.9±0.7 mm deep (n=10 experiments), similar to the Thermocool catheter and much smaller than the FEF catheter (15.2±1.1 mm deep×16.1±2 mm wide). These results are summarized in Table 1.
TABLE-US-00001 TABLE 1 Power Steam Catheter Width (mm) Depth (mm) Starting ohms Δ ohms (W) Pops FEF: 2 min (n = 20) 9.1 ± 1.7 11.8 ± 1.7 122.7 ± 5.7 32.7 ± 5.9 20 1 FEF: 4 min (n = 10) 16.1 ± 2.0 15.2 ± 1.1 124.9 ± 5.2 45.5 ± 5.1 20 1 Insulated, non-FEF catheter (n = 10) 6.9 ± 0.75 9.8 ± 1.1 175.7 ± 28.0 49.6 ± 22.2 20 8 40 W Thermocool: 90 s (n = 20) 10.4 ± 1.2 6.2 ± 1.5 .sup. 120 ± 4.3 18.2 ± 8.3 40 6 40 W Thermocool HNS: 90 s (n = 20) 11.1 ± 1.0 6.9 ± 1.1 122.9 ± 8.7 21.3 ± 8.7 40 9 30 W Thermocool NS, 4 min (n = 6) 13.8 ± 1.1 mm 8.4 mm ± 1 mm.sup. 134.8 ± 10.6 26.0 ± 9.9 20 5
[0073] Further data was collected using an infrared thermal camera.
[0074] These data are summarized in
[0075] The risk of steam pops was lower with FEF ablation due to more uniform tissue heating. As discussed above, steam pops occur when localized tissue heating leads to boiling of water within the tissue. Despite deeper ablation lesions, the incidence of steam pops was much lower with FEF ablation (2 steam pops out of 30 lesions for FEF vs 15 out of 40 lesions with the Thermocool catheter vs. 8 out of 10 with insulated solid-tip control catheter), as summarized in Table 1. To investigate the safety of FEF ablation and mechanism by which steam pops are eliminated, the amount of tissue that was heated to 100° C. during ablations using FEF and Thermocool catheters were compared with NS and HNS irrigation. The tissue reaching 100° C. during lesions is readily identified in thermal imaging sections, and the amount of tissue reaching this temperature using 2-dimensional planimetry of the 100° C. isotherm as a surrogate for the total tissue volume heated to this temperature were compared.
[0076]
[0077] These examples show that in an ex vivo porcine heart model the FEF catheter tip achieves much deeper ablation lesions than conventional RF catheters using lower power and causing fewer steam pops. Indeed, in a direct comparison with conventional catheters, FEF can reproducibly achieve over double the lesion depth. Steam pop incidence was shown to be significantly lessened, which in use would lower the risk of potentially life-threatening perforation of the heart and tamponade. Further, the control insulated catheter with a planar end was unable to achieve a similar temperature distribution or depth of lesions as the FEF catheter constructed in accord with embodiments of the instant disclosure. The results of these examples were validated using real-time infrared thermal imagery, showing that RF ablation with conventional catheters generate the greatest increase in temperature near the catheter-tissue interface where the electric field is highest. There is shown to be a rapid fall off in the amount of delivered electric energy with distance from the catheter tip, and most of the lesion volume is created by thermal conduction. Attempts at increasing power with standard RF catheters will inevitably be limited by hyperthermia of these more superficial tissue layers with risk of steam pop. The planimetered data discussed above demonstrate a significantly higher volume of tissue that reaches 100° C. with standard RF ablation than FEF. Without being bound by theory, higher energy delivery to tissue is likely the mechanism for the larger volume of tissue heated to 100° C. using half-normal saline irrigant, and consistent with recent reports suggesting more steam pops with half-normal saline than normal saline. In contrast, FEF ablation achieves more uniform and deeper heating of the tissue, with more of the lesion created by resistive than conductive heating.
[0078] These examples show that FEF technology using a novel catheter tip geometry achieves more uniform and deep lesions through a collimative effect on the electric field. The data reported herein suggests that FEF technology can create deeper ablation lesions than conventional RF ablation catheter technology with an improved safety margin. FEF technology can be used to target arrhythmic foci located at sites that are challenging to ablate with conventional technology, such as the LV summit, interventricular septum, and papillary muscles as well as other intramural and intramyocardial sites.
[0079] The Examples disclosed herein using an illustrative embodiment of the FEF catheter tip design demonstrate that the electric field remains confined to a narrow tissue region thus avoiding the rapid fall-off in energy delivery from the tissue surface that is inherent to conventional RF technology. FEF ablation according to the current disclosure advantageously allows significantly deeper ablation than current RF catheter technologies with an improved safety margin. The catheter is designed for use with both RF energy from standard generators as well as with PFA.
[0080] The foregoing description has been presented for purposes of illustration. It is not exhaustive and is not limited to precise forms or embodiments disclosed. Modifications and adaptations of the embodiments will be apparent from consideration of the specification and practice of the disclosed embodiments. For example, the described implementations include hardware, but systems and methods consistent with the present disclosure can be implemented with hardware and software. In addition, while certain components have been described as being coupled to one another, such components may be integrated with one another or distributed in any suitable fashion.
[0081] Moreover, while illustrative embodiments have been described herein, the scope includes any and all embodiments having equivalent elements, modifications, omissions, combinations (e.g., of aspects across various embodiments), adaptations or alterations based on the present disclosure. The elements in the claims are to be interpreted broadly based on the language employed in the claims and not limited to examples described in the present specification or during the prosecution of the application, which examples are to be construed as nonexclusive. Further, the steps of the disclosed methods can be modified in any manner, including reordering steps or inserting or deleting steps.
[0082] The features and advantages of the disclosure are apparent from the detailed specification, and thus, it is intended that the appended claims cover all systems and methods falling within the true spirit and scope of the disclosure. As used herein, the indefinite articles “a” and “an” mean “one or more.” Similarly, the use of a plural term does not necessarily denote a plurality unless it is unambiguous in the given context. Words such as “and” or “or” mean “and/or” unless specifically directed otherwise. Further, since numerous modifications and variations will readily occur from studying the present disclosure, it is not desired to limit the disclosure to the exact construction and operation illustrated and described, and accordingly, all suitable modifications and equivalents may be resorted to, falling within the scope of the disclosure.
[0083] As used herein, unless specifically stated otherwise, the term “or” encompasses all possible combinations, except where infeasible. For example, if it is stated that a component may include A or B, then, unless specifically stated otherwise or infeasible, the component may include A, or B, or A and B. As a second example, if it is stated that a component may include A, B, or C, then, unless specifically stated otherwise or infeasible, the component may include A, or B, or C, or A and B, or A and C, or B and C, or A and B and C.
[0084] Other embodiments will be apparent from consideration of the specification and practice of the embodiments disclosed herein. It is intended that the specification and examples be considered as example only, with a true scope and spirit of the disclosed embodiments being indicated by the following claims.